AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Ludger Klimek
Public Documents
13
August 25, 2024
Short-course subcutaneous treatment with birch pollen allergoids greatly improves sym...
Ralph Mosges, Esther Raskopf, Ludger Klimek, et al.
January 31, 2024
Inhaled Corticosteroids in early COVID-19 -- a tale of many facets
Ludger Klimek, Cezmi Akdis, Marek Jutel, et al.
May 08, 2023
House dust mite SCIT reduces asthma risk and significantly improves long-term rhiniti...
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
October 20, 2021
Management and outcome of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hyper...
Margitta Worm, A. Alexiou, Andrea Bauer, et al.
August 24, 2022
TARGET – Real-World-Evidence study on the long-term benefits of MCT ® -associated pol...
Silvia Kruppert, Vogelberg C, Ludger Klimek, et al.
May 19, 2022
Real-world evidence for the long-term effect of allergen immunotherapy: current statu...
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
June 24, 2021
COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics...
Marek Jutel, María José Torres, Oscar Palomares, et al.
February 18, 2021
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis w...
Ioana Agache, Yang Song, Pablo Alonso-Coello, et al.
January 01, 2021
Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of...
Ludger Klimek, Natalija Novak, Beatriz Cabanillas, et al.
January 15, 2021
Allergen immunotherapy: the growing role of observational and randomised trial “real-...
Giovanni Paoletti, Danilo Di Bona, Derek Chu, et al.
December 28, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-AR...
Ludger Klimek, Marek Jutel, Cezmi Akdis, et al.
August 28, 2020
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on...
Jean Bousquet, Detlef Schroder-Bernhardi, Claus Bachert, et al.
← Previous
1
2
Next →